About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

FDA Approves Animas Vibe Insulin Pump and Continuous Glucose Monitoring System

by Vishnuprasad on December 3, 2014 at 7:34 PM
Font : A-A+

FDA Approves Animas Vibe Insulin Pump and Continuous Glucose Monitoring System

Animas Corporation has announced Food and Drug Administration (FDA) approval of the Animas Vibe insulin pump and Continuous Glucose Monitoring (CGM) system for the management of insulin-requiring diabetes in adults ages 18 and older.

As the first and only integrated system featuring Dexcom G4 PLATINUM sensing technology with proven accuracy, Animas Vibe allows patients to view glucose data and administer insulin right from the pump; simplifying and aiding their ability to make more informed decisions to fine tune insulin delivery and manage their diabetes.

Advertisement

The Animas Vibe system provides patients with their latest glucose readings on the pump screen and a complete view of glucose highs, lows, and rates of change over time. This information complements fingerstick testing results and can be used to help guide immediate and long - term insulin delivery therapy adjustments.

CGM technology measures glucose levels every five minutes and provides real - time glucose values, as well as trend information. CGM has been shown to improve glycemic control in adult patients 25 years and older via lower HbA1c levels, less frequent hypoglycemia, and reduced glucose variability.
Advertisement

"For many people who are insulin dependent, diabetes is a demanding disease that can require day- to-day and hour -by-hour management.

We are pleased to now offer people with diabetes in the U.S. a solution with CGM technology that provides the ability to make more informed decisions to manage their disease, which can ultimately improve blood glucose control," said Dr. Brian Levy, Chief Medical Officer, Animas Corporation.

Animas Vibe also offers precise insulin dosing with a low basal increment of 0.025 U/hr across all available ranges (0.025 U/hr to 25.00 U/hr) and a low bolus increment of 0.05 U across all available bolus ranges (0.05 U to 35.00 U). Animas Vibe users can also personalize dosing by choosing individual insulin - to-carb ratios, insulin sensitivity factors, and blood glucose targets in 30-minute increments with up to 12 personal settings.



Source: Medindia
Advertisement

Advertisement
Advertisement

Recommended Reading

Latest Medical Gadgets

New Dialysis Device Effectively Treats Severe Liver Failure
A new dialysis device developed by researchers to treat individuals with severe liver failure is safe and effective.
Tiny Video Capsule: A New Hope for Endoscopy
The magnetically controlled capsule endoscopy shows promising results in treating issues related to stomach.
Affordable Smartphone Attachment Enables Convenient Blood Pressure Monitoring
Scientists have developed an affordable, user-friendly clip that utilizes a smartphone's camera and flash to measure blood pressure at the user's fingertip.
 Developing Wireless Patch System to Detect Sleep Apnea at Home
Recent progress in the development of wearable devices has presented alternative ways for sleep monitoring at home, which could be useful in sleep apnea detection.
Non-Invasive Brain Imaging: A Tool to Help Paralysis Patients
Researchers develop non-invasive brain imaging techniques to help people with disabilities.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

FDA Approves Animas Vibe Insulin Pump and Continuous Glucose Monitoring System Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests